ClearKlens – Hygiene, Assured

The reliable approach to critical environment contamination control for the Life Sciences Industry

Hygiene assurance is of paramount importance for pharmaceutical manufacturing facilities, where controlling contamination for both surfaces and equipment is a complex challenge and represents a significant drain on resources.

ClearKlens® IPA

Diversey’s total solutions approach forges partnerships with our customers to deliver the convenience of a comprehensive solution in solving their hygiene challenges. Working closely together, we develop robust solutions and ensure safe pharmaceutical production, as well as clarity on cleaning procedures and the chemicals to be used. We create pioneering applications that balance your sustainability and operational objectives, translating our chemistry, resource management and data analysis into productivity, safety and product quality to drive your business.
Cleaning and disinfection of surfaces is fundamental to maintain the cleanliness of operations. Without a reliable and efficient programme of disinfection that achieves key industry priorities - as demanded by your customers and regulators – a significant threat to your brand trust remains. Our team will upgrade and tailor your hygiene programmes to world-class standards while keeping a strict control on your budget.  

read more

watch the video

ClearKlens® Biocide Range

Constantly shifting governance and regulatory requirements - such as REACH and BPR - add to the challenge in preventing and controlling contamination. Diversey lead in actively interpreting and achieving compliance across the industry. Validation is vital in selecting suitable cleaning agents and determining the extent of your cleaning processes. You no doubt appreciate the role cleaning protocols play in controlling your production environment; by applying our expertise in selecting the best detergents for the roles they perform will take your operations to another level.

Identifying the right detergent is crucial to deliver enhancements to your business that really make a difference. Your manufacturing facilities can enjoy substantial efficiencies and resource savings when we ensure an as-close-to-perfect protocol is used. Our reliable and innovative approach to critical environment solutions embraces sterile and non-sterile production. We accelerate pharmaceutical standard operating procedures, while reducing waste volume and cost.And protecting your product from contamination.

read more

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey